Cardiovascular Systems, Inc. (NASDAQ:CSII) headquartered in St. Paul, will host a conference call for the investment community to discuss the 1Q21 financial results on 4th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.csi360.com
Earnings Expectation
Cardiovascular Systems, Inc. is reporting first quarter earnings results on Wednesday 4th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.22 per share from $ 56.29 million in revenue. For the full year, analysts predict revenues of $ 269.39 million, while looking forward to loss of $ 0.41 per share.
The Company Outlook
Revenue for 1Q21 are expected in a range of $ 55.00 million ~ $ 58.00 million
Click Here For More Historical Outlooks Of Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary OAS, a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions.
